Close
Smartlab Europe
Achema middle east

News

Ashfield Advisory takes strategic step forward with two new additions to senior leadership team

Ashfield Advisory, an ecosystem of healthcare advisory and consulting businesses, part of UDG Healthcare plc., has announced two senior leadership appointments. Mary-Kate McGarry joins in the new position of Vice President of Strategy and Emer Jameson, steps into the role...

Vibalogics invests an additional $50 million to further expand cGMP manufacturing capacity for viral vectors

Vibalogics, a global contract development and manufacturing organization (CDMO), has today announced that it has initiated the first stage of a planned $50 million dollar investment at its Cuxhaven, Germany facility, expanding early-to-late phase clinical virotherapy manufacturing capacity. The investment...

MaxiVision Eye Hospitals launches Mucormycosis (Black Fungus) Early Detection Center

MaxiVision Eye Hospitals group, the pioneers in the industry of eye care medical services have launched “Mucormycosis (Black Fungus) Early Detection Center” at its Somajiguda Branch in Hyderabad to identify the virulent fungal infection in its initial stage preventing...

mCureX and Samyang sign MoU for mRNA vaccine development

OliX Pharmaceuticals’ subsidiary mCureX has entered a memorandum of understanding (MoU) with Samyang Holdings to develop a messenger ribonucleic acid (mRNA) vaccine for Covid-19. The companies are co-developing a vaccine that could potentially target Covid-19 viral variants. According to the deal,...

AGC Biologics Heidelberg Facility to Further Supply Plasmid DNA for COVID-19 Vaccine

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced its partnership with BioNTech SE to further supply Plasmid DNA (pDNA) starting material for the Pfizer-BioNTech COVID-19 vaccine, at AGC’s Heidelberg, Germany facility. “We are honored...

U.S. FDA Approves PREVNAR 20, Pfizer’s Pneumococcal 20-valent Conjugate Vaccine for Adults Ages 18 Years or Older

Pfizer Inc. announced that the U.S. FDA has approved PREVNAR 20™ for the prevention of invasive disease and pneumonia caused by the 20 Streptococcus pneumoniae (pneumococcus) serotypes in the vaccine in adults ages 18 years and older. Following today’s...

Bruker launches timsTOF SCP for Unbiased Single Cell 4D-Proteomics and Next-gen timsTOF Pro 2 with Unprecedented Proteomic Depth

At Bruker’s virtual 4D-Proteomics™ eXceed Symposium (eXceed Symposia 2021 | Bruker), Bruker Corporation (Nasdaq: BRKR) today announced the launch of two new timsTOF instruments. They further advance and enable new applications and methods in unbiased proteomics, epiproteomics/PTM characterization, and...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »